Mouad Abdulrahim Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Biography and Research Information
OverviewAI-generated summary
Mouad Abdulrahim's research focuses on the molecular mechanisms underlying cancer, particularly acute myeloid leukemia. His recent work, published in 2024, investigates how pyrimidine depletion can enhance the effectiveness of combination therapies involving targeted treatments and immunotherapy in acute myeloid leukemia. Abdulrahim also has experience with clinical case reports, with publications in 2023 on corticosteroid-induced psychosis and in 2022 on the management of psychosis associated with Graves’ disease.
His scholarly work includes three publications with 21 total citations and an h-index of 3. Abdulrahim collaborates with researchers from institutions including the University of Arkansas for Medical Sciences and the University of Arkansas – Fort Smith. His recent activity indicates ongoing engagement in research.
Metrics
- h-index: 3
- Publications: 3
- Citations: 24
Selected Publications
-
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia (2024)
-
Corticosteroid-Induced Psychosis: A Report of Three Cases (2023)
Collaboration Network
Top Collaborators
- Management of Psychosis Associated with Graves’ Disease: A Rare Case Report
- Corticosteroid-Induced Psychosis: A Report of Three Cases
- Management of Psychosis Associated with Graves’ Disease: A Rare Case Report
- Corticosteroid-Induced Psychosis: A Report of Three Cases
- Management of Psychosis Associated with Graves’ Disease: A Rare Case Report
- Management of Psychosis Associated with Graves’ Disease: A Rare Case Report
- Management of Psychosis Associated with Graves’ Disease: A Rare Case Report
- Corticosteroid-Induced Psychosis: A Report of Three Cases
- Corticosteroid-Induced Psychosis: A Report of Three Cases
- Corticosteroid-Induced Psychosis: A Report of Three Cases
- Corticosteroid-Induced Psychosis: A Report of Three Cases
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
Similar Researchers
Based on overlapping research topics